Company / Operating Income
SOLENO THERAPEUTICS INC Operating Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$9.4M
FY2025
5-year range
-$187.7M / $9.4M
FY2021-FY2025
Trend
+105.0%
vs FY2024
Sector context
#53 of 202
Health Care
What the data says
At $9M, SOLENO THERAPEUTICS INC's operating income ranks #53 of 202 in the Health Care sector. Operating Income returned to growth in FY2025 after 2 years of decline, reaching $9M.
Based on SEC 10-K filings.
$9M in FY2025.
Improved from -$41M to $9M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#53 of 202 in Health CareTop 26% of 202This company $9.4M Sector average $86.7M
▼
-89.1% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 105.0% year-over-year.
- Ranks #53 out of 202 companies in the Health Care sector.
- Lowest operating income in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.4M | +105.0% |
| FY2024 | -$187.7M | -353.5% |
| FY2023 | -$41.4M | -69.6% |
| FY2022 | -$24.4M | +22.6% |
| FY2021 | -$31.5M | +13.1% |
| FY2020 | -$36.3M | -54.5% |
| FY2019 | -$23.5M | -64.2% |
| FY2018 | -$14.3M | -17.5% |
| FY2017 | -$12.2M | -46.2% |
| FY2016 | -$8.3M | +31.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026